Association of fetuin-A level and diabetes risk

JAMA

Volumn 300, Issue 19, 2008, Pages 2247-

  Stefan, Norbert ^a   Häring, Hans Ulrich ^a   Schulze, Matthias B ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FETUIN A; ALPHA2HS GLYCOPROTEIN; PLASMA PROTEIN; UNCLASSIFIED DRUG;

HUMAN; LETTER; LIFESTYLE; MEDICAL RESEARCH; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; AGED; BLOOD; METABOLISM; MIDDLE AGED; NOTE;

AGED; BLOOD PROTEINS; DIABETES MELLITUS, TYPE 2; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 56649115762     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.614     Document Type: Letter

References (5)

1. Ix JH, Wassel CL, Kanaya AM, et al; Health ABC Study. Fetuin-A and incident diabetes mellitus in older persons. JAMA. 2008;300(2):182-188.
2. Stefan N, Fritsche A, Weikert C, et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008;57(10):2762-2667.
3. Auberger P, Falquerho L, Contreres JO, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and antimitogenic activity. Cell. 1989;58(4):631-640.
4. Stefan N, Hennige AM, Staiger H, et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006;29(4):853-857.
5. Incidence of diabetes in the United States. National Diabetes Information Clearinghouse. http://diabetes.niddk.nih.gov/dm/pubs/statistics/#11. Accessed May 22, 2007.